Latest

E-cigarettes vaping
Health

Vaping companies sue to delay U.S. e-cigarette review

By Associated Press

Online pharmacy
Pharmalot

A battle over verifying online Canadian pharmacies goes to court

By Ed Silverman

Novartis Window
Biotech

Novartis ousted top scientists over manipulation of data for gene therapy

By Damian Garde and Matthew Herper

Ebola gloves and boots
Health

Modern science has delivered the world powerful tools to defeat Ebola. It is not enough

By Helen Branswell

Pharmalot

Pharmalittle: Canada may ease price caps on rare disease drugs; lawmakers renew generic pricing probe

By Ed Silverman

Pharmalot

Sanders and Cummings renew probe into generic pricing they say was ‘stonewalled’

By Ed Silverman

Regeneron
Biotech

Regeneron drug proves effective in genetic form of high cholesterol

By Matthew Herper and Damian Garde

The READOUT
The Readout

Why the FDA snapped at Novartis & how a unicorn loses its horn

By Damian Garde

Opioid Crisis Lawsuits
Morning Rounds

Screening for illicit drug use & aerobic exercise for stroke

By Shraddha Chakradhar

Dementia Friendly Cities
First Opinion

With no dementia cure in sight, it’s time for communities to become dementia friendly

By Nancy Berlinger

FDA
First Opinion

Novartis violated FDA’s sacred principle: In God we trust, all others must bring data

By Robert M. Califf

CT scan
Health Tech

With brain trauma, surgeons don’t always know if an operation will help. Could AI change that?

By Jacquelyn Corley

Women supporting women
Health Tech

One health care startup at a time, this venture capitalist wants to harness the investing power of women

By Megan Thielking

Vasant "Vas" Narasimhan
The Pharmalot View

Memo to the Novartis CEO: When in doubt, give the FDA a heads-up

By Ed Silverman

Alzheimer's Iowa state fair
Politics

Alzheimer’s advocates are swarming the Iowa State Fair, pushing politicians to consider policies to fight the disease 

By Nicholas Florko

Methadone clinic
Health

For the first time, U.S. panel recommends screening adults for illicit drug use

By Brittany Flaherty

Jeffrey Leiden
Biotech

Vertex, known for cystic fibrosis drugs, sets its sights on taming pain

By Jonathan Saltzman — Boston Globe

Pharmalot

Pharmalittle: Grassley presses Novartis over data manipulation; top Trump drug policy adviser is leaving

By Ed Silverman

The READOUT
The Readout

Sorting out Sarepta & biotech lands in Shanghai

By Damian Garde

insulin
Morning Rounds

Little progress on diabetes care & a painful denture mishap

By Shraddha Chakradhar

transparency in healthcare - executive order
First Opinion

Bringing transparency to the notion of price transparency

By Robin Gelburd

In the Lab

The entire human brain in ‘unprecedented’ detail, thanks to powerful MRI

By Sharon Begley

Gingipains in the brain
Biotech

An old idea that’s gaining new traction: curing Alzheimer’s by targeting gum-disease bacteria

By Sharon Begley

Swallowed Dentures
Health

Missing dentures found stuck in throat 8 days after surgery

By Associated Press

Marisa Boidi
Biotech

Toddler denied $2.1m gene therapy will now get it for free

By Jonathan Saltzman — Boston Globe

Vertex
Pharmalot

Scotland tells Vertex its cystic fibrosis drugs are not cost-effective

By Ed Silverman

Cancer Drug Prices
Pharmalot

Few Americans took obesity drugs thanks to doctor doubts and spotty insurance

By Ed Silverman

Ebola health workers July 2019
Health

For the first time, clinical trial results show Ebola drugs improve survival rates

By Helen Branswell

Frayed rope
First Opinion

Five things I wish I knew earlier in my journey with chronic pain

By Tom Bowen

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy